Mureşan D, Oană A, Nicolae I, Alecu M, Moşescu L, Benea V, Flueraş M
Dermato-Venereal Research Center, Bucharest, Romania.
Arch Roum Pathol Exp Microbiol. 1990 Jan-Mar;49(1):31-5.
In 42 urticaria patients, magnesium, histamine and IgE were dosed. Magnesium, IgE and histamine variations were followed in urticaria evolution, during acute phase and clinical remission. We noticed magnesium, histamine, IgE values variations depending on disease evolution and applied therapeutic scheme. Therefore: At disease starting point, histamine presented 3.5 times higher values than the normal ones. The value decreases following a curve which tends to reach normal values during clinical remission. At disease starting point, magnesium presented values under the inferior limit of the normal, 0.5 m mol/L respectively, as a mean. The value increases towards the normal limit during clinical remission. Immunoglobulins E follow a similar curve to histamine one, presenting 1,250 U/L values at the starting point, that, under medication, influence decrease between normal limits (800 U/L), during clinical remission. Analyzing the variations of biochemical parameters, the authors emphasize magnesium substitution treatment in urticaria.
对42例荨麻疹患者进行了镁、组胺和免疫球蛋白E(IgE)的剂量测定。在荨麻疹演变过程中,即急性期和临床缓解期,对镁、IgE和组胺的变化进行了跟踪。我们注意到镁、组胺、IgE值会根据疾病演变和应用的治疗方案而变化。因此:在疾病起始点,组胺值比正常值高3.5倍。该值沿着一条曲线下降,在临床缓解期趋于达到正常值。在疾病起始点,镁的值低于正常下限,平均分别为0.5毫摩尔/升。在临床缓解期,该值向正常上限增加。免疫球蛋白E遵循与组胺相似的曲线,在起始点呈现1250 U/L的值,在药物治疗下,在临床缓解期影响降至正常范围(800 U/L)之间。通过分析生化参数的变化,作者强调了荨麻疹的镁替代治疗。